Hepatic artery infusion chemotherapy (HAIC) plus sintilimab and bevacizumab biosimilar (IBI305) in initial unresectable hepatocellular carcinoma (HCC): A retrospective study. This is an ASCO Meeting ...
Current status of PD-(L)1 inhibitor usage in advanced or metastatic non-small cell lung cancer: A national survey of oncologists in China. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する